Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| MORGAN STANLEY | 605.5K | $1.0M | 8.03% | +530.3K | 2026-06-30 |
| Diametric Capital, LP | 256.6K | -- | 3.40% | -113.4K | 2026-06-30 |
| RENAISSANCE TECHNOLOGIES LLC | 127.9K | -- | 1.70% | +60.0K | 2026-06-30 |
| CITADEL ADVISORS LLC | 96.0K | -- | 1.27% | +50.7K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 70.9K | -- | 0.94% | -13.2K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 70.8K | -- | 0.94% | -13.5K | 2026-06-30 |
| PHILADELPHIA TRUST CO | 50.0K | -- | 0.66% | -25.0K | 2026-06-30 |
| VANGUARD FIDUCIARY TRUST CO | 37.6K | -- | 0.50% | -- | 2026-06-30 |
| JANE STREET GROUP, LLC | 35.9K | -- | 0.48% | +13.1K | 2026-06-30 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 32.6K | -- | 0.43% | -- | 2026-06-30 |
